Products
Platform
Research
Market
Learn
Compare Tata India Pharma & Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.1 | 1.87 |
NAV | ₹30.96 | ₹40.43 |
Fund Started | 04 Dec 2015 | 25 Jun 2018 |
Fund Size | ₹1295.83 Cr | ₹6226.82 Cr |
Exit Load | Exit load of 0.25% if redeemed within 30 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.1
1.87
NAV
₹30.96
₹40.43
Fund Started
04 Dec 2015
25 Jun 2018
Fund Size
₹1295.83 Cr
₹6226.82 Cr
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | 1.94% | 6.17% |
3 Year | 22.69% | 28.01% |
5 Year | 18.06% | 20.59% |
1 Year
1.94%
6.17%
3 Year
22.69%
28.01%
5 Year
18.06%
20.59%
Holding Analysis
Equity | 98.28% | 97.55% |
Cash | 1.72% | 2.45% |
Equity
98.28%
97.55%
Cash
1.72%
2.45%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 10.03% |
Apollo Hospitals Enterprise Ltd. | 5.06% |
Lupin Ltd. | 4.88% |
Cipla Ltd. | 4.86% |
Healthcare Global Enterprises Ltd. | 4.68% |
Torrent Pharmaceuticals Ltd. | 4.68% |
Aster DM Healthcare Ltd. | 4.63% |
Alkem Laboratories Ltd. | 4.46% |
Max Healthcare Institute Ltd. | 3.95% |
Divi's Laboratories Ltd. | 3.86% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.58% |
Dr. Reddy's Laboratories Ltd. | 9.10% |
Divi's Laboratories Ltd. | 8.75% |
Aurobindo Pharma Ltd. | 8.25% |
Cipla Ltd. | 6.92% |
Lupin Ltd. | 5.43% |
Alkem Laboratories Ltd. | 4.05% |
Biocon Ltd. | 3.11% |
Gland Pharma Ltd. | 2.97% |
Mankind Pharma Ltd. | 2.95% |
Fund Manager
Name | Meeta Shetty | Dharmesh Kakkad |
Start Date | 11 Nov 2024 | 23 Feb 2021 |
Name
Meeta Shetty
Dharmesh Kakkad
Start Date
11 Nov 2024
23 Feb 2021
About Fund
Description | The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 04 Dec 2015 | 25 Jun 2018 |
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
04 Dec 2015
25 Jun 2018